港股異動 | 華虹半導體(1347.HK)漲超5% 機構料次季收入將好於指引
格隆匯6月5日丨華虹半導體(1347.HK)現報17.48港元,漲5.56%,暫成交9697萬港元,最新總市值225億港元。中金近日發研報指,6月1日,華虹宏力宣佈5月8寸晶圓產量和功率分立器件投片量創新高。該行認為,這進一步證明,經歷1季度較為疲軟的業績後,華虹半導體公司盈利開始觸底反彈。考慮5月晶圓投片量創下新高,該行認為公司2季度收入有望好於指引,同時建議投資者密切關注下半年需求。維持跑贏行業評級,目標價20港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.